Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof

Details for Australian Patent Application No. 2003276836 (hide)

Owner Epigenesis Pharmaceuticals LLC

Inventors Leonard, Sherry A.; Johnson, Keith A.

Agent Fisher Adams Kelly

Pub. Number AU-B-2003276836

PCT Number PCT/US03/18944

PCT Pub. Number WO2004/012653

Priority 60/477,987 11.06.03 US; 60/389,242 17.06.02 US

Filing date 17 June 2003

Wipo publication date 23 February 2004

Acceptance publication date 10 May 2007

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/5685 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07J 31/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing sulfur

Event Publications

19 February 2004 Complete Application Filed

  Priority application(s): 60/477,987 11.06.03 US; 60/389,242 17.06.02 US

1 April 2004 Application Open to Public Inspection

  Published as AU-B-2003276836

16 June 2005 Assignment before Grant

  Epigenesis Pharmaceuticals, Inc. The application has been assigned to Epigenesis Pharmaceuticals, LLC.

10 May 2007 Application Accepted

  Published as AU-B-2003276836

19 July 2007 Section 223 Application Allowed

  Epigenesis Pharmaceuticals LLC The time in which to pay the exam response has been extended to 30 Jun 2007. Address for service in Australia - FISHER ADAMS KELLY GPO Box 1413 Brisbane QLD 4001 2005

13 September 2007 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003276837-Combination of anti-muscarinic agents and non-glucocorticoid steroids

2003276835-POLYPEPTIDE CLEAVAGE PROCESS